Task: Answer the multiple-choice question.
Query: Which drug exhibits a 18.043% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a COc1ccc(OC)c(NC(=O)CN(Cc2ccccc2)S(C)(=O)=O)c1
b O=C(O)c1ccc(/C=N/Nc2ncc(Cl)cc2Cl)cc1
Answer: b. O=C(O)c1ccc(/C=N/Nc2ncc(Cl)cc2Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(O)c1ccc(/C=N/Nc2ncc(Cl)cc2Cl)cc1
O=C(O)c1ccc(/C=N/Nc2ncc(Cl)cc2Cl)cc1
4-[(E)-[(3,5-dichloropyridin-2-yl)hydrazinylidene]methyl]benzoic acid